speb/financial-data huggingface dataset:
Stock screener scorecard for VCEL (quarterly, report date 2026-03-31)
Altman Z-score: 10.13751485042249 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.2236217150090374%
Capitalized R&D asset: 15048450
ROCI (R&D adjusted): -1.5842725504439765%
Rosenberg metric: -3.2899489866262237
Free cash flow margin: 5.600292290829375%
Revenue growth: -26.359801114961577%
Rule of 40 score: -20.7595088241322
Market cap: 2300623616 (Mid Cap ($2B-$10B))
P/E ratio: 74.81395348837209
Debt to equity: 0.2668
Free cash flow (dilution adjusted): 3832000
Operating income: -8064000
Net income: -6302000
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for VCV (quarterly, report date 2026-02-28)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 515214240 (Small Cap ($300M-$2B))
P/E ratio: 42.5
Debt to equity: 0.6187
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VCV (annual, report date 2026-02-28)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.4232361492712835%
Capitalized R&D asset: 0
Free cash flow margin: 236.50814893527624%
Revenue growth: -29.645685728633087%
Rule of 40 score: 206.86246320664316
Market cap: 515214240 (Small Cap ($300M-$2B))
P/E ratio: 42.5
Debt to equity: 0.6187
Free cash flow (dilution adjusted): 30113743
Net income: 12374728
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VIRT (quarterly, report date 2026-03-31)
Altman Z-score: 0.6857117488938379 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 83.35948665728911%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.7422158296094565%
Free cash flow margin: -6.005407468034214%
Revenue growth: 13.754385820203796%
Rule of 40 score: 7.748978352169582
Market cap: 12854739968 (Large Cap ($10B-$200B))
P/E ratio: 7.246688741721854
Debt to equity: 4.1175
Free cash flow (dilution adjusted): -66257000
Operating income: 623984000
Net income: 346596000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1960.HK (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 75439490.4458599 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2776.T (annual, report date 2026-01-31)
Altman Z-score: 2.4249732539665136 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.448944052554609%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.9659641400805725%
Free cash flow margin: -2.077940382690011%
Revenue growth: 128.60508976987867%
Rule of 40 score: 126.52714938718866
Market cap: 7358063400.000001 (Mid Cap ($2B-$10B))
P/E ratio: 25.62740415928001
Debt to equity: 1.3759756204991773
Free cash flow (dilution adjusted): -3790604.5965003916
Operating income: 3872734.3954034997
Net income: 1874621.311047271
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3261.T (annual, report date 2025-12-31)
Altman Z-score: 2.4568735229803025 (Grey Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.2938215632975857%
Free cash flow margin: -16.0861328348507%
Revenue growth: -18.856367365509882%
Rule of 40 score: -34.942500200360584
Market cap: 2445776798.706173 (Mid Cap ($2B-$10B))
Debt to equity: 0.8356311039573074
Free cash flow (dilution adjusted): -3514008.055750911
Operating income: 82405.21705773288
Net income: -19896.426059714853
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 3475.T (annual, report date 2025-10-31)
Altman Z-score: 3.243498316177825 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.639058916160373%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.980140128840217%
Free cash flow margin: -2.1031189090784843%
Revenue growth: -9.070941602525377%
Rule of 40 score: -11.17406051160386
Market cap: 39012565662.00001 (Large Cap ($10B-$200B))
P/E ratio: 25.643757074082647
Debt to equity: 1.9110087756475427
Free cash flow (dilution adjusted): -7458862.897985705
Operating income: 19073476.283300843
Net income: 9885172.189733593
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 5704.T (annual, report date 2025-12-31)
Altman Z-score: 2.5194824275316856 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -64.40108821039394%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.99182951023805%
Free cash flow margin: 15.406868691883105%
Revenue growth: 5.291099771663667%
Rule of 40 score: 20.697968463546772
Market cap: 2104586329.6006668 (Mid Cap ($2B-$10B))
Debt to equity: 0.4547547031690737
Free cash flow (dilution adjusted): 3174784.2209577393
Operating income: 662285.0201393773
Net income: -8079055.047631226
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 6099.HK (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.168777640519256%
Capitalized R&D asset: 0
Free cash flow margin: -136.16110308631548%
Revenue growth: 26.674634456137735%
Rule of 40 score: -109.48646863017774
Market cap: 15446611239.18509 (Large Cap ($10B-$200B))
P/E ratio: 1.2507860943900397
Debt to equity: 1.6074065339840344
Free cash flow (dilution adjusted): -4584432417.728571
Net income: 1764217525.5642858
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for APGO.V (annual, report date 2025-11-30)
Altman Z-score: 228.07811139947012 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -27.86944401493389%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -28.937056400530782%
Rule of 40 score: 0
Market cap: 297586744.28999996 (Micro Cap ($50M-$300M))
Debt to equity: 0.005284380517208622
Free cash flow (dilution adjusted): -7829670.000000001
Operating income: -6877067.142857144
Net income: -6700960.714285715
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for BARK.V (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 828921.96 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EEX (annual, report date 2025-12-31)
Altman Z-score: 0.2078571027135363 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.434801428416838%
Free cash flow margin: 4.9633146309883465%
Revenue growth: 16.198595787362084%
Rule of 40 score: 21.16191041835043
Market cap: 878755178.5200001 (Small Cap ($300M-$2B))
Debt to equity: 1.5026564344746163
Free cash flow (dilution adjusted): 23000000
Operating income: 22500000
Net income: -30700000
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for KEP (annual, report date 2025-12-31)
Altman Z-score: 0.6285830761691311 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.867827938734814%
Capitalized R&D asset: 62911418.98304894
ROCI (R&D adjusted): 7.217535178507951%
Rosenberg metric: 114.09041556743627
Free cash flow margin: 5.118202913346099%
Revenue growth: 6.447677085278391%
Rule of 40 score: 11.56587999862449
Market cap: 30461856676649.312 (Mega Cap (>= $200B))
P/E ratio: 3.514833942485927
Debt to equity: 2.6948953412026655
Free cash flow (dilution adjusted): 3437297883.7340302
Operating income: 9437802087.752363
Net income: 6027259007.865582
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LGL (annual, report date 2025-12-31)
Altman Z-score: 19.755278306949705 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.785015986934419%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5429449859357625%
Free cash flow margin: 0.21587910769968818%
Revenue growth: -2.978822434256458%
Rule of 40 score: -2.76294332655677
Market cap: 37665001.25 (Nano Cap (< $50M))
P/E ratio: 49.88741887417219
Debt to equity: 0
Free cash flow (dilution adjusted): 9000
Operating income: 249000
Net income: 755000
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MX (annual, report date 2025-12-31)
Altman Z-score: 779.0203453053458 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.640333177290998%
Capitalized R&D asset: 43720.1637411989
ROCI (R&D adjusted): -10.871752395714566%
Rosenberg metric: -0.26748686178130515
Free cash flow margin: -31.637593648663763%
Revenue growth: -7.075482302998595%
Rule of 40 score: -38.71307595166236
Market cap: 133830913913.991 (Large Cap ($10B-$200B))
Debt to equity: 0.1881812688821752
Free cash flow (dilution adjusted): -39353.64522118909
Operating income: -21572.97744643267
Net income: -20671.66929780028
Long score: 4 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SAPR11.SA (annual, report date 2025-12-31)
Altman Z-score: 0.8469433857201875 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -35.514602468709%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7672014565111125%
Free cash flow margin: 61.68657236112332%
Revenue growth: 18.661020920796627%
Rule of 40 score: 80.34759328191994
Market cap: 11784277507.568619 (Large Cap ($10B-$200B))
P/E ratio: 5.666694961438441
Debt to equity: 0.5987038480841212
Free cash flow (dilution adjusted): 811125182.4817518
Operating income: 28617700.729927003
Net income: 379483211.6788321
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for STTK (annual, report date 2025-12-31)
Altman Z-score: 16.736200341892527 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -54.85131690739168%
Capitalized R&D asset: 104826670
ROCI (R&D adjusted): -39.81253526978127%
Free cash flow margin: -4694.8%
Revenue growth: -82.52053836741828%
Rule of 40 score: -4777.3205383674185
Market cap: 348604802.25 (Small Cap ($300M-$2B))
Debt to equity: 0.029384634057531254
Free cash flow (dilution adjusted): -46948000
Operating income: -51508000
Net income: -48809000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for VIRT (annual, report date 2025-12-31)
Altman Z-score: 0.7648674571865516 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 359.53121520569493%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.269954696900273%
Free cash flow margin: 9.759704943506792%
Revenue growth: 26.24895331825486%
Rule of 40 score: 36.00865826176165
Market cap: 2869195490.0699997 (Mid Cap ($2B-$10B))
P/E ratio: 3.1451372520125753
Debt to equity: 4.549063723932719
Free cash flow (dilution adjusted): 354484000
Operating income: 1875578000
Net income: 912264000
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0590.HK (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14125814784 (Large Cap ($10B-$200B))
P/E ratio: 0.8518062397372741
Debt to equity: 0.31829999999999997
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0968.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 19300261888 (Large Cap ($10B-$200B))
P/E ratio: 3.458752044870297
Debt to equity: 0.37549999999999994
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1125.HK (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 238344080 (Micro Cap ($50M-$300M))
Debt to equity: 0.8351000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2239.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 399666368 (Small Cap ($300M-$2B))
Debt to equity: 0.0141
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2239.HK (annual, report date 2025-12-31)
Altman Z-score: 9.510865975631111 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 2672832.6561380783
ROCI (R&D adjusted): -4.730262399601103%
Rosenberg metric: 0.01723254348882514
Free cash flow margin: -40.09372236609855%
Revenue growth: 4.994931386752049%
Rule of 40 score: -35.0987909793465
Market cap: 399666368 (Small Cap ($300M-$2B))
Debt to equity: 0.0141
Free cash flow (dilution adjusted): -758138.4318766067
Operating income: -878677.1208226221
Net income: -577397.6863753214
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for 2279.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1080240768 (Small Cap ($300M-$2B))
P/E ratio: 1.1870557991834265
Debt to equity: 0.6156
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2635.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3888899840 (Mid Cap ($2B-$10B))
P/E ratio: 12.030848329048842
Debt to equity: 0.21789999999999998
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2691.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.510170652659786%
Capitalized R&D asset: 0
Free cash flow margin: 1224.782406314758%
Revenue growth: -1.8445291913100867%
Rule of 40 score: 1222.9378771234478
Market cap: 5087378432 (Mid Cap ($2B-$10B))
P/E ratio: 0.8638682745825602
Debt to equity: 0.22940000000000002
Free cash flow (dilution adjusted): 768320232.52822
Net income: 29729488.64109985
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2911.T (annual, report date 2026-03-31)
Altman Z-score: 3.122469839504672 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.784921585285127%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.955169925497921%
Free cash flow margin: -1.4513228838918277%
Revenue growth: -10.254262678823018%
Rule of 40 score: -11.705585562714846
Market cap: 4095926016 (Mid Cap ($2B-$10B))
P/E ratio: 0.11489850400637946
Debt to equity: 0.08929999999999999
Free cash flow (dilution adjusted): -697960.4604604604
Operating income: 549211.7117117117
Net income: 1458858.858858859
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2911.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4095926016 (Mid Cap ($2B-$10B))
P/E ratio: 0.11489850400637946
Debt to equity: 0.08929999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3003.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1343616319488 (Mega Cap (>= $200B))
P/E ratio: 0.07452664512034946
Debt to equity: 2.4337
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3686.T (annual, report date 2026-03-31)
Altman Z-score: 2.487424684494723 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -35.562077008085566%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -35.32380565725058%
Free cash flow margin: -49.31392442609472%
Revenue growth: -30.788809606724733%
Rule of 40 score: -80.10273403281946
Market cap: 2867597056 (Mid Cap ($2B-$10B))
Debt to equity: 0.0701
Free cash flow (dilution adjusted): -4514201.701701702
Operating income: -3723267.017017017
Net income: -3115578.078078078
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for 3686.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2867597056 (Mid Cap ($2B-$10B))
Debt to equity: 0.0701
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3842.T (annual, report date 2026-03-31)
Altman Z-score: 3.6627272286340284 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 31.27072038691057%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.690239365690967%
Free cash flow margin: 10.76070106960778%
Revenue growth: 10.053047805999919%
Rule of 40 score: 20.8137488756077
Market cap: 3036978432 (Mid Cap ($2B-$10B))
P/E ratio: 0.06377704744099144
Debt to equity: 0.1198
Free cash flow (dilution adjusted): 2865872.122122122
Operating income: 2053910.1601601602
Net income: 1828778.7787787789
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 3842.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3036978432 (Mid Cap ($2B-$10B))
P/E ratio: 0.06377704744099144
Debt to equity: 0.1198
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4627.T (quarterly, report date 2026-04-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13022732288 (Large Cap ($10B-$200B))
P/E ratio: 0.052333582306962806
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4975.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 152642289664 (Large Cap ($10B-$200B))
P/E ratio: 0.09098765249667382
Debt to equity: 0.0064
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6100.HK (annual, report date 2025-12-31)
Altman Z-score: 1.5492932262702253 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.749544328833133%
Capitalized R&D asset: 83489955.98520316
ROCI (R&D adjusted): 1.3660871395916505%
Rosenberg metric: 0.015204869184166907
Free cash flow margin: 9.629652754454805%
Revenue growth: -0.4685393539980365%
Rule of 40 score: 9.161113400456768
Market cap: 1024196032 (Small Cap ($300M-$2B))
P/E ratio: 1.8766066838046271
Debt to equity: 0.0391
Free cash flow (dilution adjusted): 27320714.285714284
Operating income: 12024285.714285715
Net income: 20131428.57142857
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6100.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1024196032 (Small Cap ($300M-$2B))
P/E ratio: 1.8766066838046271
Debt to equity: 0.0391
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6814.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 234537467904 (Mega Cap (>= $200B))
P/E ratio: 0.07110718953380672
Debt to equity: 0.1527
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6905.T (quarterly, report date 2025-11-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 51993579520 (Large Cap ($10B-$200B))
Debt to equity: 0.0043
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7078.T (annual, report date 2026-03-31)
Altman Z-score: 2.85856388255291 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.202959659549734%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -16.648990916096473%
Free cash flow margin: -6.007093586226729%
Revenue growth: -12.664195316385468%
Rule of 40 score: -18.671288902612197
Market cap: 3478204160 (Mid Cap ($2B-$10B))
Debt to equity: 0.3357
Free cash flow (dilution adjusted): -1717192.1921921922
Operating income: -2593831.3313313313
Net income: -1086392.6426426426
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 7078.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3478204160 (Mid Cap ($2B-$10B))
Debt to equity: 0.3357
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7083.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2214778880 (Mid Cap ($2B-$10B))
P/E ratio: 1.1505844698734626
Debt to equity: 3.5858
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 7911.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1360892526592 (Mega Cap (>= $200B))
P/E ratio: 0.11310138693764889
Debt to equity: 0.3704
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8237.HK (annual, report date 2025-12-31)
Altman Z-score: -0.8795945952408725 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 174.99034077737423%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -19.154412443034005%
Free cash flow margin: -128.56820404785194%
Revenue growth: 14.263341707329078%
Rule of 40 score: -114.30486234052286
Market cap: 217105936 (Micro Cap ($50M-$300M))
P/E ratio: 0.2705723739554708
Debt to equity: 0.0981
Free cash flow (dilution adjusted): -2196401.028277635
Operating income: -2668766.066838046
Net income: 22919023.136246786
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 8237.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 217105936 (Micro Cap ($50M-$300M))
Debt to equity: 0.0981
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8242.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 313945063424 (Mega Cap (>= $200B))
P/E ratio: 0.05920394862187506
Debt to equity: 0.43939999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8428.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 76140632 (Micro Cap ($50M-$300M))
Debt to equity: -0.5584347598481875
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 8620.HK (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 73920000 (Micro Cap ($50M-$300M))
Debt to equity: 2.4908
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 9735.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2727193083904 (Mega Cap (>= $200B))
P/E ratio: 0.13674233329505633
Debt to equity: 0.045700000000000005
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9740.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 38140669952 (Large Cap ($10B-$200B))
P/E ratio: 0.09334675458609733
Debt to equity: 0.1192
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ACU.V (quarterly, report date 2025-12-31)
Altman Z-score: -7.830429290197454 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -179.0341656699808%
Capitalized R&D asset: 243615.28866250068
ROCI (R&D adjusted): -72.14977537917306%
Rosenberg metric: -3.451542489940349
Free cash flow margin: -88.16794694447879%
Revenue growth: -56.13659943207854%
Rule of 40 score: -144.3045463765573
Market cap: 1110970 (Nano Cap (< $50M))
Debt to equity: 0.5805
Free cash flow (dilution adjusted): -275883.9416058394
Operating income: -813659.1240875912
Net income: -865897.0802919707
Long score: 1 | Short score: 17
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ALP (annual, report date 2026-03-31)
Altman Z-score: -24.564054790482697 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -809.2402123424021%
Capitalized R&D asset: 9033980
ROCI (R&D adjusted): -167.16193789033417%
Free cash flow margin: -33971.134020618556%
Rule of 40 score: -33971.134020618556
Market cap: 5083428 (Nano Cap (< $50M))
Debt to equity: 0.0212
Free cash flow (dilution adjusted): -32952000
Operating income: -23096000
Net income: -38626000
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ALU.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 78211672 (Micro Cap ($50M-$300M))
P/E ratio: 0.17027027027027025
Debt to equity: 0.4799
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for APE.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5983268864 (Mid Cap ($2B-$10B))
P/E ratio: 18.78414234431091
Debt to equity: 1.5416999999999998
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ATLN (quarterly, report date 2026-03-31)
Altman Z-score: -0.6917662909150524 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.289014997799747%
Free cash flow margin: -5.505832592828308%
Revenue growth: 108.15975649012479%
Rule of 40 score: 102.65392389729648
Market cap: 73171856 (Micro Cap ($50M-$300M))
Debt to equity: 9.4912
Free cash flow (dilution adjusted): -13758354
Operating income: -14903794
Net income: -30689124
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BNRG (annual, report date 2025-12-31)
Altman Z-score: -15.873987663689315 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -388.12249570692626%
Capitalized R&D asset: 2193792.940914394
ROCI (R&D adjusted): -84.72406766026145%
Rosenberg metric: -0.7518211656511598
Free cash flow margin: -3055.0387596899222%
Rule of 40 score: -3055.0387596899222
Market cap: 1421226 (Nano Cap (< $50M))
Debt to equity: 1.6723
Free cash flow (dilution adjusted): -3717924.5283018863
Operating income: -4005660.37735849
Net income: -4372641.509433962
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BNRG (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1421226 (Nano Cap (< $50M))
Debt to equity: 1.6723
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CAF.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 79652000 (Micro Cap ($50M-$300M))
P/E ratio: 11.76470588235294
Debt to equity: 0.13970000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CAF.AX (annual, report date 2025-06-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 126.14894585166083%
Capitalized R&D asset: 0
Free cash flow margin: 24.856581532416502%
Revenue growth: 9.095990754489858%
Rule of 40 score: 33.95257228690636
Market cap: 79652000 (Micro Cap ($50M-$300M))
P/E ratio: 11.76470588235294
Debt to equity: 0.13970000000000002
Free cash flow (dilution adjusted): 6201960.784313725
Net income: 3365359.477124183
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for CAM.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.5543472122834086%
Capitalized R&D asset: 0
Free cash flow margin: 211.86516807071447%
Revenue growth: -28.308129432843117%
Rule of 40 score: 183.55703863787136
Market cap: 95513648 (Micro Cap ($50M-$300M))
P/E ratio: 6.971677559912854
Debt to equity: 0.34259999999999996
Free cash flow (dilution adjusted): 6773224.183006536
Net income: 2000041.8300653594
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CAM.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 95513648 (Micro Cap ($50M-$300M))
P/E ratio: 6.971677559912854
Debt to equity: 0.34259999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CCX.AX (annual, report date 2024-06-30)
Altman Z-score: -1.163502675854853 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -428.7006435901896%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -55.85912289867544%
Free cash flow margin: -14.648916850927382%
Revenue growth: -50.770713109911306%
Rule of 40 score: -65.41962996083869
Market cap: 19257890 (Nano Cap (< $50M))
Debt to equity: 1.0662
Free cash flow (dilution adjusted): -12852666.666666666
Operating income: -24234666.666666668
Net income: -61973333.333333336
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CGCL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.7157664707358848 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.366899277093933%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.0395028012521266%
Revenue growth: 16.91703210025477%
Rule of 40 score: 16.91703210025477
Market cap: 229213945856 (Mega Cap (>= $200B))
P/E ratio: 0.17357650377366518
Debt to equity: 3.3473
Operating income: 35620389.99576092
Net income: 29971916.066129718
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for CGCL.NS (annual, report date 2026-03-31)
Altman Z-score: 1.881649760108304 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.933083198417057%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.2591988300158055%
Free cash flow margin: -202.1840540736304%
Revenue growth: 30.6104244581627%
Rule of 40 score: -171.5736296154677
Market cap: 229213945856 (Mega Cap (>= $200B))
P/E ratio: 0.17357650377366518
Debt to equity: 3.3473
Free cash flow (dilution adjusted): -931830436.6256889
Operating income: 111682174.65027554
Net income: 100588384.90885969
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for CORT (quarterly, report date 2026-03-31)
Altman Z-score: 36.182635919142896 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.828468291673655%
Capitalized R&D asset: 132437700
ROCI (R&D adjusted): -6.263570460270837%
Rosenberg metric: -0.5791291476501789
Free cash flow margin: -24.266386906241852%
Revenue growth: -18.415337043908472%
Rule of 40 score: -42.68172395015033
Market cap: 10237047808 (Large Cap ($10B-$200B))
P/E ratio: 115.17142857142859
Debt to equity: 0.0151
Free cash flow (dilution adjusted): -40016000
Operating income: -49601000
Net income: -31202000
Long score: 4 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CREO.L (annual, report date 2025-12-31)
Altman Z-score: -0.2596058240642608 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.93634496919918%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -37.64478764478764%
Free cash flow margin: -356.6666666666667%
Revenue growth: 62.16216216216216%
Rule of 40 score: -294.50450450450455
Market cap: 66191156 (Micro Cap ($50M-$300M))
P/E ratio: 0.09166163150943397
Debt to equity: 0.08199999999999999
Free cash flow (dilution adjusted): -28918918.91891892
Operating income: -26351351.35135135
Net income: 7162162.162162162
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CREO.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 66191156 (Micro Cap ($50M-$300M))
Debt to equity: 0.08199999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CXO.AX (annual, report date 2025-06-30)
Altman Z-score: 12.096471420359952 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.788777483257142%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.168447248990242%
Revenue growth: -101.25256177597429%
Rule of 40 score: -101.25256177597429
Market cap: 776832320 (Small Cap ($300M-$2B))
Debt to equity: 0.0139
Free cash flow (dilution adjusted): -41400653.59477124
Operating income: -16503921.56862745
Net income: -15274509.80392157
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CXO.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 776832320 (Small Cap ($300M-$2B))
Debt to equity: 0.0139
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DBG.PA (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1483794432 (Small Cap ($300M-$2B))
P/E ratio: 11.286525411992802
Debt to equity: 0.7259
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DFCH.L (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.103174289441437%
Capitalized R&D asset: 0
Free cash flow margin: 50.23518850987433%
Revenue growth: 32.67282749733672%
Rule of 40 score: 82.90801600721105
Market cap: 115141376 (Micro Cap ($50M-$300M))
P/E ratio: 0.08614864864864866
Debt to equity: 0.1489
Free cash flow (dilution adjusted): 37812162.16216216
Net income: 20485135.135135137
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for DFCH.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 115141376 (Micro Cap ($50M-$300M))
P/E ratio: 0.08614864864864866
Debt to equity: 0.1489
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DNLI (quarterly, report date 2026-03-31)
Altman Z-score: 4.570289751973468 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.285168599412648%
Capitalized R&D asset: 203085850
ROCI (R&D adjusted): -9.91533051839633%
Rule of 40 score: 0
Market cap: 3667782400 (Mid Cap ($2B-$10B))
Debt to equity: 0.0432
Free cash flow (dilution adjusted): -156757000
Operating income: -137357000
Net income: -128447000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for DRX.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2571534080 (Mid Cap ($2B-$10B))
P/E ratio: 0.554054054054054
Debt to equity: 0.629
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DRX.L (annual, report date 2025-12-31)
Altman Z-score: 2.590870040945025 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.515655654084594%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.232453893442624%
Free cash flow margin: 9.277088318771218%
Revenue growth: -5.431500465983226%
Rule of 40 score: 3.8455878527879923
Market cap: 2571534080 (Mid Cap ($2B-$10B))
P/E ratio: 0.554054054054054
Debt to equity: 0.629
Free cash flow (dilution adjusted): 675810810.8108108
Operating income: 853918918.918919
Net income: 98648648.64864865
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for EFOI (quarterly, report date 2026-03-31)
Altman Z-score: -30.372632470149487 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.325774754346183%
Capitalized R&D asset: 241080
ROCI (R&D adjusted): -4.384231198785278%
Rosenberg metric: 0.1796116504854369
Free cash flow margin: 7.2708113804004215%
Revenue growth: -2.666666666666667%
Rule of 40 score: 4.604144713733755
Market cap: 18279666 (Nano Cap (< $50M))
Debt to equity: 0.0466
Free cash flow (dilution adjusted): 69000
Operating income: -141000
Net income: -140000
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for EOG.V (annual, report date 2026-03-31)
Altman Z-score: 13.69415012164324 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -301.14292474204893%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -25.25207737818254%
Rule of 40 score: 0
Market cap: 409159552 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -3115134.532374101
Operating income: -5192426.618705036
Net income: -5402569.0647482015
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for EOG.V (quarterly, report date 2026-03-31)
Altman Z-score: 13.942689909532252 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -208.63555614370674%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -17.148094759933805%
Revenue growth: -993.0491941901449%
Rule of 40 score: -993.0491941901449
Market cap: 409159552 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -1687078.4172661873
Operating income: -3526055.3956834534
Net income: -3742966.9064748203
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for EPOW (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 20433550 (Nano Cap (< $50M))
Debt to equity: 5.2515
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for EPOW (annual, report date 2025-12-31)
Altman Z-score: -0.17574114760495702 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 564869.0857440114
ROCI (R&D adjusted): -26.649984478608346%
Rosenberg metric: -0.1198530613286743
Free cash flow margin: -76.76540776814406%
Revenue growth: -25.527573642905537%
Rule of 40 score: -102.2929814110496
Market cap: 20433550 (Nano Cap (< $50M))
Debt to equity: 5.2515
Free cash flow (dilution adjusted): -5090219
Operating income: -2289641.1428571427
Net income: -2376511.4285714286
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ERL.AX (annual, report date 2024-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -160.49444446254125%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -162.50590408187864%
Rule of 40 score: 0
Market cap: 14609991 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -630036.6666666666
Operating income: -665171.3333333334
Net income: -656938
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for GAUZ (quarterly, report date 2025-06-30)
Altman Z-score: -2.792916472319483 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 2466914.844239969
ROCI (R&D adjusted): -15.753558764206815%
Rosenberg metric: -0.3085646411922969
Free cash flow margin: -31.45507130746983%
Revenue growth: -2.4067140631880584%
Rule of 40 score: -33.861785370657884
Market cap: 5806623 (Nano Cap (< $50M))
Debt to equity: 3.5431
Free cash flow (dilution adjusted): -1860766.9616519173
Operating income: -3690265.4867256638
Net income: -3166961.651917404
Long score: 0 | Short score: 17
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for GENM.TO (quarterly, report date 2026-03-31)
Altman Z-score: -4.046698104573029 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -13.5159546988663%
Rule of 40 score: 0
Market cap: 190406304 (Micro Cap ($50M-$300M))
Debt to equity: -0.024554890742436115
Free cash flow (dilution adjusted): -3010679.1366906473
Operating income: -3787369.0647482015
Net income: -12299246.76258993
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for HEMO.L (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 49435716 (Nano Cap (< $50M))
Debt to equity: 1.7512
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HEMO.L (annual, report date 2025-12-31)
Altman Z-score: -6.7276672092996606 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -905.4509426998734%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -172.22289965089018%
Rule of 40 score: 0
Market cap: 49435716 (Nano Cap (< $50M))
Debt to equity: 1.7512
Free cash flow (dilution adjusted): -4750087.837837838
Operating income: -6298498.6486486485
Net income: -13189681.081081081
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for INSP (quarterly, report date 2026-03-31)
Altman Z-score: 7.750621566617699 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.0079763737789333%
Capitalized R&D asset: 50526770
ROCI (R&D adjusted): -0.03266532663945527%
Rosenberg metric: -2.2489776280971854
Free cash flow margin: -13.47423783989872%
Revenue growth: -23.968603782560383%
Rule of 40 score: -37.4428416224591
Market cap: 1417318912 (Small Cap ($300M-$2B))
P/E ratio: 11.72272727272727
Debt to equity: 0.0373
Free cash flow (dilution adjusted): -27566000
Operating income: -1118000
Net income: -11294000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for JSFB.NS (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.273818946777656%
Capitalized R&D asset: 0
Free cash flow margin: 12.63210642483128%
Revenue growth: 4.683072308701818%
Rule of 40 score: 17.3151787335331
Market cap: 51021938688 (Large Cap ($10B-$200B))
P/E ratio: 0.12297256600364258
Debt to equity: 1.2296436556597132
Free cash flow (dilution adjusted): 48394796.52395083
Net income: 34593916.91394659
Long score: 2 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for JSFB.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 0.3613907075450504%
Rule of 40 score: 0.3613907075450504
Market cap: 56763392000 (Large Cap ($10B-$200B))
P/E ratio: 0.13751785018366808
Net income: 16376368.815275872
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for JUSTDIAL.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 6.100925529005307%
Rule of 40 score: 6.100925529005307
Market cap: 61996494848 (Large Cap ($10B-$200B))
P/E ratio: 0.09356363301090374
Debt to equity: 0.0166
Operating income: 8113725.076484861
Net income: 17535605.021626752
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for L1M.AX (annual, report date 2024-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -70.15792343252541%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -23.951038286448473%
Rule of 40 score: 0
Market cap: 4757596 (Nano Cap (< $50M))
Debt to equity: 0.0143
Free cash flow (dilution adjusted): -2028774
Operating income: -1177890.6666666667
Net income: -2211235.3333333335
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for LFS (quarterly, report date 2026-03-31)
Altman Z-score: 3.308957384047227 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.742911668137455%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.231742675563606%
Free cash flow margin: -4.969298595443211%
Revenue growth: -8.869836280714749%
Rule of 40 score: -13.83913487615796
Market cap: 57030152 (Micro Cap ($50M-$300M))
P/E ratio: 23.545454545454543
Debt to equity: 0.5974
Free cash flow (dilution adjusted): -918475.8946446446
Operating income: 1036717.9054054053
Net income: 777827.8528528528
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LHAI (quarterly, report date 2026-03-31)
Altman Z-score: 13.868743262384882 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.261121474913833%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.7591502589712937%
Free cash flow margin: -67.10170413675478%
Revenue growth: -3.3522737119728507%
Rule of 40 score: -70.45397784872763
Market cap: 14913366 (Nano Cap (< $50M))
Debt to equity: 0.051
Free cash flow (dilution adjusted): -3292996
Operating income: -214300
Net income: -134670
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for MPT (quarterly, report date 2026-03-31)
Altman Z-score: -0.1378330689562648 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.3423962611434623%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.0274778486891694%
Free cash flow margin: -5.884196536607621%
Revenue growth: -6.760695711358205%
Rule of 40 score: -12.644892247965826
Market cap: 2894803968 (Mid Cap ($2B-$10B))
P/E ratio: 20.50453076388679
Debt to equity: 2.1256
Free cash flow (dilution adjusted): -14832000
Operating income: 140203000
Net income: 33107000
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)